相关实验视频
Updated: Jun 20, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Mettl3-m6A-YTHDF1轴促进了代谢功能障碍相关的脂肪性肝病中的线粒体功能障碍
Shuowen Wang1, Wanyu Zhang2, Zijun Wang3
1Beijing Tongren Hospital, Capital Medical University, Beijing 100176, China; Capital Institute of Pediatrics, Beijing 100020, China.
N6-甲基氨酸 (m6A) 修改影响了代谢功能障碍相关的脂肪性肝病 (MASLD) 的肝脏健康. 针对Mettl3-m6A-YTHDF1通路可以改善线粒体功能并缓解MASLD.
科学领域:
- * 分子生物学 * 分子生物学
- * 肝病学 肝病学是一门专业.
- * 表观遗传学 是一种表观遗传学.
背景情况:
- *与代谢功能障碍相关的脂肪性肝病 (MASLD) 是与N6-甲基氨酸 (m6A) mRNA修饰和线粒体功能障碍相关的日益严重的健康问题.
- * 了解m6A与线粒体健康之间的相互作用对于MASLD的发病过程至关重要.
研究的目的:
- * 调查m6A修饰在MASLD肝脏线粒体功能障碍中的作用.
- * 为了确定关键的分子参与者和参与MASLD中m6A介导的线粒体调节的途径.
- *为MASLD病原和潜在的治疗点提供一个新的视角.
主要方法:
- *利用高通量查来分析MASLD模型小鼠中的转录组和蛋白质组变化.
- * 采用西方涂抹,蓝色本地凝电泳 (BNGE),点涂抹和海马分析进行验证.
- *研究了甲基转移酶3 (Mettl3) 和YTH N6-甲基氨酸RNA结合蛋白1 (YTHDF1) 在线粒体功能上的作用.
主要成果:
- *高脂肪饮食通过上调Mettl3和降低YTHDF1.1,诱导MASLD中的异常m6A修饰.
- *Mettl3的敲击损害了肝氧化酸化 (OXPHOS) 和线粒体呼吸链 (MRC) 功能,而Mettl3的过度表达促进了这些过程.
- *YTHDF1淘汰对抗了Mettl3的影响,并抑制了线粒体OXPHOS,突出了其作为m6A读者的关键作用.
结论:
- *Mettl3-m6A-YTHDF1轴,特别是YTHDF1,在MASLD中调节线粒体呼吸链损伤.
- *调节这一轴为增强线粒体功能提供了一个有前途的治疗策略.
- * 向Mettl3-m6A-YTHDF1通路可能会缓解MASLD的症状并减少疾病的进展.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
相关概念视频
Mitochondrial Membranes
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
The Inner Mitochondrial Membrane
ATP Synthase: Mechanism
Mitochondria
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...